The COVID-19 disease is a multisystem disease due to in part to the vascular endothelium
injury. Lasting effects and long-term sequalae could persist after the infection and may be …

Background: Endothelial dysfunction has a key role in the pathogenesis of coronavirus
disease 2019 (COVID-19) and its disabling complications. We designed a case-control …

Numerous studies have linked coronavirus disease 2019 (COVID‐19) with endothelial
dysfunction and reported elevated levels of endothelial biomarkers in this disease. We …

Abstract Coronavirus disease 2019 (COVID-19) increases the risk of several non-pulmonary
complications such as acute myocardial injury, renal failure or thromboembolic events. A …

Background Persistent symptoms including breathlessness, fatigue, and decreased exercise
tolerance have been reported in patients after acute SARS‐CoV‐2 infection. The biological …

The COVID-19 pandemic is an unprecedented healthcare emergency causing mortality and
illness across the world. Although primarily affecting the lungs, the SARS-CoV-2 virus also …

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV2), emerging in Wuhan, China and …

Abstract Purpose of Review To review current literature on endothelial dysfunction with
previous coronaviruses, and present available data on the role of endothelial dysfunction in …

Several risk factors are associated with a worse outcome for COVID-19 patients; the most
recognized are demographic characteristics such as older age and male gender, and pre …

Background Endothelial dysfunction is one of the underlying mechanisms to vascular and
cardiac complications in patients with COVID-19. We sought to investigate the systemic …